Deerfield Management Company, L.P. (Series C) Atri Cure, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Atri Cure, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 11,138 shares of ATRC stock, worth $417,229. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,138Holding current value
$417,229% of portfolio
0.01%Shares
5 transactions
Others Institutions Holding ATRC
# of Institutions
222Shares Held
51.8MCall Options Held
33.5KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA4.91MShares$184 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$173 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA3.97MShares$149 Million0.02% of portfolio
-
Alliancebernstein L.P. New York, NY3.57MShares$134 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3.06MShares$115 Million1.62% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.74B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...